HSP70 fusion protein conjugates and uses thereof
US9217018B2 · kind B2 · utility
0Cited by
15References
8Claims
0Family size
Inventors
Key dates
| Filing date | Dec 15, 2012 |
| Grant date | Dec 22, 2015 |
| Priority date | — |
| Expiry date | Dec 15, 2032 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2319/50
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to novel therapies that utilize HSP70 fusion proteins for the treatment of disorders or conditions regulated by HSP70.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.